Cargando…

Low FODMAP Diet: Evidence, Doubts, and Hopes

Food is often considered to be a precipitating factor of irritable bowel syndrome (IBS) symptoms. In recent years, there has been a growing interest in FODMAPs (Fermentable Oligo-, Di-, Mono-saccharides, And Polyols), which can be found in many common foods. A low FODMAP diet (LFD) is increasingly s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellini, Massimo, Tonarelli, Sara, Nagy, Attila G., Pancetti, Andrea, Costa, Francesco, Ricchiuti, Angelo, de Bortoli, Nicola, Mosca, Marta, Marchi, Santino, Rossi, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019579/
https://www.ncbi.nlm.nih.gov/pubmed/31947991
http://dx.doi.org/10.3390/nu12010148
_version_ 1783497552110288896
author Bellini, Massimo
Tonarelli, Sara
Nagy, Attila G.
Pancetti, Andrea
Costa, Francesco
Ricchiuti, Angelo
de Bortoli, Nicola
Mosca, Marta
Marchi, Santino
Rossi, Alessandra
author_facet Bellini, Massimo
Tonarelli, Sara
Nagy, Attila G.
Pancetti, Andrea
Costa, Francesco
Ricchiuti, Angelo
de Bortoli, Nicola
Mosca, Marta
Marchi, Santino
Rossi, Alessandra
author_sort Bellini, Massimo
collection PubMed
description Food is often considered to be a precipitating factor of irritable bowel syndrome (IBS) symptoms. In recent years, there has been a growing interest in FODMAPs (Fermentable Oligo-, Di-, Mono-saccharides, And Polyols), which can be found in many common foods. A low FODMAP diet (LFD) is increasingly suggested for IBS treatment. However, long-term, large, randomized controlled studies are still lacking, and certainties and doubts regarding LFDs have grown, often in a disorderly and confused manner. Some potential LFD limitations and concerns have been raised, including nutritional adequacy, cost, and difficulty in teaching the diet and maintaining it. Most of these limitations can be solved with the involvement of a skilled nutritionist, who can clearly explain the different phases of the LFD and ensure nutritional adequacy and compliance. Further studies should focus on new methods of teaching and learning the LFD and on predictors of response. Moreover, particular interest should be focused on the possible use of LFD in gastrointestinal diseases other than functional disorders and, possibly, also in non-gastrointestinal diseases. The aim of the present review was to clarify the effective and appropriate indications and limitations of an LFD and to discuss its possible future uses.
format Online
Article
Text
id pubmed-7019579
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70195792020-03-09 Low FODMAP Diet: Evidence, Doubts, and Hopes Bellini, Massimo Tonarelli, Sara Nagy, Attila G. Pancetti, Andrea Costa, Francesco Ricchiuti, Angelo de Bortoli, Nicola Mosca, Marta Marchi, Santino Rossi, Alessandra Nutrients Review Food is often considered to be a precipitating factor of irritable bowel syndrome (IBS) symptoms. In recent years, there has been a growing interest in FODMAPs (Fermentable Oligo-, Di-, Mono-saccharides, And Polyols), which can be found in many common foods. A low FODMAP diet (LFD) is increasingly suggested for IBS treatment. However, long-term, large, randomized controlled studies are still lacking, and certainties and doubts regarding LFDs have grown, often in a disorderly and confused manner. Some potential LFD limitations and concerns have been raised, including nutritional adequacy, cost, and difficulty in teaching the diet and maintaining it. Most of these limitations can be solved with the involvement of a skilled nutritionist, who can clearly explain the different phases of the LFD and ensure nutritional adequacy and compliance. Further studies should focus on new methods of teaching and learning the LFD and on predictors of response. Moreover, particular interest should be focused on the possible use of LFD in gastrointestinal diseases other than functional disorders and, possibly, also in non-gastrointestinal diseases. The aim of the present review was to clarify the effective and appropriate indications and limitations of an LFD and to discuss its possible future uses. MDPI 2020-01-04 /pmc/articles/PMC7019579/ /pubmed/31947991 http://dx.doi.org/10.3390/nu12010148 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Bellini, Massimo
Tonarelli, Sara
Nagy, Attila G.
Pancetti, Andrea
Costa, Francesco
Ricchiuti, Angelo
de Bortoli, Nicola
Mosca, Marta
Marchi, Santino
Rossi, Alessandra
Low FODMAP Diet: Evidence, Doubts, and Hopes
title Low FODMAP Diet: Evidence, Doubts, and Hopes
title_full Low FODMAP Diet: Evidence, Doubts, and Hopes
title_fullStr Low FODMAP Diet: Evidence, Doubts, and Hopes
title_full_unstemmed Low FODMAP Diet: Evidence, Doubts, and Hopes
title_short Low FODMAP Diet: Evidence, Doubts, and Hopes
title_sort low fodmap diet: evidence, doubts, and hopes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019579/
https://www.ncbi.nlm.nih.gov/pubmed/31947991
http://dx.doi.org/10.3390/nu12010148
work_keys_str_mv AT bellinimassimo lowfodmapdietevidencedoubtsandhopes
AT tonarellisara lowfodmapdietevidencedoubtsandhopes
AT nagyattilag lowfodmapdietevidencedoubtsandhopes
AT pancettiandrea lowfodmapdietevidencedoubtsandhopes
AT costafrancesco lowfodmapdietevidencedoubtsandhopes
AT ricchiutiangelo lowfodmapdietevidencedoubtsandhopes
AT debortolinicola lowfodmapdietevidencedoubtsandhopes
AT moscamarta lowfodmapdietevidencedoubtsandhopes
AT marchisantino lowfodmapdietevidencedoubtsandhopes
AT rossialessandra lowfodmapdietevidencedoubtsandhopes